Responding to some of the criticisms in Anant Phadke’s review of Katherine Eban’s Bottle of Lies: Ranbaxy and the Dark Side of Indian Pharma, “Indian Pharma Fraud and Beyond” (EPW, 18 January 2020), this author, who is the protagonist of the book, contends that the review downplays the importance of critical drug testing and is too forgiving of the transgressions of the Indian pharma industry.
